N4 Pharma (LON:N4P) Shares Up 21.4% – Here’s What Happened

N4 Pharma Plc (LON:N4P)’s stock price was up 21.4% during mid-day trading on Wednesday . The company traded as high as GBX 0.80 ($0.01) and last traded at GBX 0.79 ($0.01). Approximately 8,145,359 shares changed hands during trading, an increase of 121% from the average daily volume of 3,678,352 shares. The stock had previously closed at GBX 0.65 ($0.01).

N4 Pharma Stock Performance

The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62. The firm has a 50-day simple moving average of GBX 0.62 and a 200 day simple moving average of GBX 0.58. The company has a market cap of £3.16 million, a price-to-earnings ratio of -55.00 and a beta of -0.37.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.